ADIENNE Pharma & Biotech Signs Service Agreement with Selexis for…

ADIENNE Pharma & Biotech has entered into a Service Agreement with Selexis for the rapid development of a manufacturing cell line for one of ADIENNE’s orphan drugs .

(PRWeb May 15, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog